Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Winter Pressures. What are they? What can be done to prevent them?

Fleming DM.

Prim Care Respir J. 2002 Sep;11(3):86-87. doi: 10.1038/pcrj.2002.86. Epub 2002 Sep 1. No abstract available.

2.

A standardized methodology for the surveillance of antimicrobial prescribing linked to clinical indications in primary care.

Smith S, Hawker JI, Smith GE, Morbey R, Johnson AP, Fleming DM, Shallcross L, Hayward AC.

J Public Health (Oxf). 2018 Sep 1;40(3):630-638. doi: 10.1093/pubmed/fdx114.

3.

Is the onset of influenza in the community age-related?

Fleming DM, Durnall H, Warburton F, Ellis JS, Zambon MC.

Epidemiol Infect. 2016 Aug;144(11):2295-305. doi: 10.1017/S0950268816000510.

PMID:
27350234
4.

Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom.

Matias G, Taylor RJ, Haguinet F, Schuck-Paim C, Lustig RL, Fleming DM.

BMC Public Health. 2016 Jun 8;16:481. doi: 10.1186/s12889-016-3128-4.

5.

Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK.

Taylor S, Taylor RJ, Lustig RL, Schuck-Paim C, Haguinet F, Webb DJ, Logie J, Matias G, Fleming DM.

BMJ Open. 2016 Jun 2;6(6):e009337. doi: 10.1136/bmjopen-2015-009337.

6.

Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom.

Fleming DM, Taylor RJ, Lustig RL, Schuck-Paim C, Haguinet F, Webb DJ, Logie J, Matias G, Taylor S.

BMC Infect Dis. 2015 Oct 23;15:443. doi: 10.1186/s12879-015-1218-z.

7.

Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012.

Cohen JM, Silva ML, Caini S, Ciblak M, Mosnier A, Daviaud I, Matias G, Badur S, Valette M, Enouf V, Paget J, Fleming DM; IBGP study team.

PLoS One. 2015 Oct 1;10(10):e0139431. doi: 10.1371/journal.pone.0139431. eCollection 2015.

8.

Influenza-attributable burden in United Kingdom primary care.

Fleming DM, Taylor RJ, Haguinet F, Schuck-Paim C, Logie J, Webb DJ, Lustig RL, Matias G.

Epidemiol Infect. 2016 Feb;144(3):537-47. doi: 10.1017/S0950268815001119. Epub 2015 Jul 13.

9.

Self-sampling for community respiratory illness: a new tool for national virological surveillance.

Elliot AJ, Bermingham A, Charlett A, Lackenby A, Ellis J, Sadler C, Sebastianpillai P, Powers C, Foord D, Povey E, Evans B, Durnall H, Fleming DM, Brown D, Smith GE, Zambon M.

Euro Surveill. 2015 Mar 12;20(10):21058.

10.

Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995-2011: analysis of a large database of primary care consultations.

Hawker JI, Smith S, Smith GE, Morbey R, Johnson AP, Fleming DM, Shallcross L, Hayward AC.

J Antimicrob Chemother. 2014 Dec;69(12):3423-30. doi: 10.1093/jac/dku291. Epub 2014 Aug 4.

PMID:
25091508
11.

Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study.

Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kroneman M, Van Kerkhove MD, Mounts AW, Paget WJ; GLaMOR Collaborating Teams.

PLoS Med. 2013 Nov;10(11):e1001558. doi: 10.1371/journal.pmed.1001558. Epub 2013 Nov 26.

12.

New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.

Poland GA, Fleming DM, Treanor JJ, Maraskovsky E, Luke TC, Ball EM, Poland CM.

Vaccine. 2013 Apr 17;31 Suppl 1:A1-20. doi: 10.1016/j.vaccine.2013.02.033.

PMID:
23587330
13.

Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.

Pebody R, Andrews N, McMenamin J, Durnall H, Ellis J, Thompson CI, Robertson C, Cottrell S, Smyth B, Zambon M, Moore C, Fleming DM, Watson JM.

Euro Surveill. 2013 Jan 31;18(5). pii: 20389.

14.

Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13.

McMenamin J, Andrews N, Robertson C, Fleming D, Durnall H, von Wissmann B, Ellis J, Lackenby A, Cottrell S, Smyth B, Zambon M, Moore C, Watson J, Pebody R.

Euro Surveill. 2013 Jan 31;18(5). pii: 20393.

15.

Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.

Pebody RG, Andrews N, Fleming DM, McMenamin J, Cottrell S, Smyth B, Durnall H, Robertson C, Carman W, Ellis J, Sebastian-Pillai P, Zambon M, Kearns C, Moore C, Thomas DR, Watson JM.

Epidemiol Infect. 2013 Mar;141(3):620-30. doi: 10.1017/S0950268812001148. Epub 2012 Jun 13.

16.

Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012.

Chalker V, Stocki T, Litt D, Bermingham A, Watson J, Fleming D, Harrison T.

Euro Surveill. 2012 Feb 9;17(6). pii: 20081. No abstract available.

17.

Ten lessons for the next influenza pandemic-an English perspective: a personal reflection based on community surveillance data.

Fleming DM, Durnall H.

Hum Vaccin Immunother. 2012 Jan;8(1):138-45. doi: 10.4161/hv.8.1.18808. Epub 2012 Jan 1. Review.

PMID:
22251996
18.

Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice.

Hardelid P, Fleming DM, Andrews N, Barley M, Durnall H, Mangtani P, Pebody R.

Vaccine. 2012 Feb 8;30(7):1371-8. doi: 10.1016/j.vaccine.2011.12.038. Epub 2011 Dec 16.

PMID:
22178524
19.

Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.

Pebody R, Hardelid P, Fleming D, McMenamin J, Andrews N, Robertson C, Thomas D, Sebastianpillai P, Ellis J, Carman W, Wreghitt T, Zambon M, Watson J.

Euro Surveill. 2011 Feb 10;16(6). pii: 19791.

20.

Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.

Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, SebastianPillai P, Ellis J, Carman W, Wreghitt T, Watson JM, Pebody RG.

Euro Surveill. 2011 Jan 13;16(2). pii: 19763.

21.

An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006.

Fleming DM, Verlander NQ, Elliot AJ, Zhao H, Gelb D, Jehring D, Nguyen-Van-Tam JS.

Epidemiol Infect. 2010 Sep;138(9):1281-8. doi: 10.1017/S0950268810000105. Epub 2010 Jan 29.

PMID:
20109259
22.

Estimating influenza vaccine effectiveness using routinely collected laboratory data.

Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, Miller E, Zambon M.

J Epidemiol Community Health. 2010 Dec;64(12):1062-7. doi: 10.1136/jech.2009.093450. Epub 2009 Nov 12.

PMID:
19910645
23.

Fatal cases of influenza a in childhood.

Johnson BF, Wilson LE, Ellis J, Elliot AJ, Barclay WS, Pebody RG, McMenamin J, Fleming DM, Zambon MC.

PLoS One. 2009 Oct 30;4(10):e7671. doi: 10.1371/journal.pone.0007671.

24.

The representativeness of sentinel practice networks.

Fleming DM, Miles J.

J Public Health (Oxf). 2010 Mar;32(1):90-6. doi: 10.1093/pubmed/fdp087. Epub 2009 Sep 15.

PMID:
19758977
25.

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M; European Influenza Surveillance Scheme.

Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280.

26.

Influenza virus resistance to oseltamivir: what are the implications?

Fleming DM, Elliot AJ, Meijer A, Paget WJ.

Eur J Public Health. 2009 Jun;19(3):238-9. doi: 10.1093/eurpub/ckp012. Epub 2009 Feb 12. No abstract available.

PMID:
19221019
27.

Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007.

Elliot AJ, Cross KW, Fleming DM.

Ann Rheum Dis. 2009 Nov;68(11):1728-33. doi: 10.1136/ard.2008.096693. Epub 2008 Nov 24.

PMID:
19029167
28.

Health benefits, risks, and cost-effectiveness of influenza vaccination in children.

Fleming DM, Elliot AJ.

Pediatr Infect Dis J. 2008 Nov;27(11 Suppl):S154-8. doi: 10.1097/INF.0b013e31818a5443.

PMID:
18955891
29.

Structured surveillance of infectious intestinal disease in pre-school children in the community: 'The Nappy Study'.

Iturriza-Gómara M, Elliot AJ, Dockery C, Fleming DM, Gray JJ.

Epidemiol Infect. 2009 Jul;137(7):922-31. doi: 10.1017/S0950268808001556. Epub 2008 Nov 19.

PMID:
19017426
30.

Does it really matter? Evaluating the Continuous Morbidity Registration--the Nijmegen project.

Fleming DM.

Eur J Gen Pract. 2008;14 Suppl 1:63-4. doi: 10.1080/13814780802436226. No abstract available.

PMID:
18949647
31.

Viral infections and acute otitis media in young children.

Elliot AJ, Fleming DM.

Clin Infect Dis. 2008 Jul 1;47(1):146-7. doi: 10.1086/588845. No abstract available.

PMID:
18522511
32.

Influenza and respiratory syncytial virus in the elderly.

Elliot AJ, Fleming DM.

Expert Rev Vaccines. 2008 Mar;7(2):249-58. doi: 10.1586/14760584.7.2.249. Review.

PMID:
18324893
33.

Acute respiratory infections and winter pressures on hospital admissions in England and Wales 1990-2005.

Elliot AJ, Cross KW, Fleming DM.

J Public Health (Oxf). 2008 Mar;30(1):91-8. doi: 10.1093/pubmed/fdn003. Epub 2008 Feb 7.

PMID:
18258786
34.

Respiratory syncytial virus: a sleeping giant?

Fleming DM, Elliot AJ.

Eur Respir J. 2007 Dec;30(6):1029-31. No abstract available.

35.

Lessons from 40 years' surveillance of influenza in England and Wales.

Fleming DM, Elliot AJ.

Epidemiol Infect. 2008 Jul;136(7):866-75. Epub 2007 Nov 30. Review.

36.

Left ventricular dysfunction is associated with intraventricular dyssynchrony by 3-dimensional echocardiography in children.

Baker GH, Hlavacek AM, Chessa KS, Fleming DM, Shirali GS.

J Am Soc Echocardiogr. 2008 Mar;21(3):230-3. Epub 2007 Sep 29.

PMID:
17904813
37.

The state of play in the battle against antimicrobial resistance: a general practitioner perspective.

Fleming DM.

J Antimicrob Chemother. 2007 Aug;60 Suppl 1:i49-52.

PMID:
17656381
38.

Skin infections and antibiotic prescribing: a comparison of surveillance and prescribing data.

Fleming DM, Elliot AJ, Kendall H.

Br J Gen Pract. 2007 Jul;57(540):569-73.

39.

A downturn in the incidence of head lice infestation?

Downs AM, Ross AM, Fleming DM, Coles GC.

Int J Dermatol. 2007 Jun;46(6):660-1. No abstract available.

PMID:
17550575
40.

Epidemic influenza and vitamin D.

Fleming DM, Elliot AJ.

Epidemiol Infect. 2007 Oct;135(7):1091-2; author reply 1092-5. No abstract available.

41.

The management of acute bronchitis in children.

Fleming DM, Elliot AJ.

Expert Opin Pharmacother. 2007 Mar;8(4):415-26. Review.

PMID:
17309336
42.

Morbidity profiles of patients consulting during influenza and respiratory syncytial virus active periods.

Fleming DM, Elliot AJ, Cross KW.

Epidemiol Infect. 2007 Oct;135(7):1099-108. Epub 2007 Feb 12.

43.

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.

Vesikari T, Fleming DM, Aristegui JF, Vertruyen A, Ashkenazi S, Rappaport R, Skinner J, Saville MK, Gruber WC, Forrest BD; CAIV-T Pediatric Day Care Clinical Trial Network.

Pediatrics. 2006 Dec;118(6):2298-312.

PMID:
17142512
44.

Changing disease incidence: the consulting room perspective.

Fleming DM, Elliot AJ.

Br J Gen Pract. 2006 Nov;56(532):820-4. No abstract available.

45.

Surveillance of influenza-like illness in England and Wales during 1966-2006.

Elliot AJ, Fleming DM.

Euro Surveill. 2006;11(10):249-50.

PMID:
17130657
47.

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):860-9.

PMID:
17006278
48.
49.
50.

Estimating the risk population in relation to influenza vaccination policy.

Fleming DM, Elliot AJ.

Vaccine. 2006 May 15;24(20):4378-85. Epub 2006 Mar 15.

PMID:
16574281

Supplemental Content

Loading ...
Support Center